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Abstract
Backgound: It has been reported that Toll-like receptor 4 (TLR4) deficiency reduces infarct size
after myocardial ischemia/reperfusion (MI/R). However, measurement of MI/R injury was limited
and did not include cardiac function. In a chronic closed-chest model we assessed whether cardiac
function is preserved in TLR4-deficient mice (C3H/HeJ) following MI/R, and whether myocardial
and systemic cytokine expression differed compared to wild type (WT).
Results: Infarct size (IS) in C3H/HeJ assessed by TTC staining after 60 min ischemia and 24h
reperfusion was significantly smaller than in WT. Despite a smaller infarct size, echocardiography
showed no functional difference between C3H/HeJ and WT. Left-ventricular developed pressure
measured with a left-ventricular catheter was lower in C3H/HeJ (63.0 ± 4.2 mmHg vs. 77.9 ± 1.7
mmHg in WT, p < 0.05). Serum cytokine levels and myocardial IL-6 were higher in WT than in
C3H/HeJ (p < 0.05). C3H/HeJ MI/R showed increased myocardial IL-1β and IL-6 expression
compared to their respective shams (p < 0.05), indicating TLR4-independent cytokine activation
due to MI/R.
Conclusion: These results demonstrate that, although a mutant TLR4 signaling cascade reduces
myocardial IS and serum cytokine levels, it does not preserve myocardial function. The
change in inflammatory response, secondary to a non-functional TLR-4 receptor, may contribute
to the observed dichotomy between infarct size and function in the TLR-4 mutant mouse.
Background
Activation of Toll-like receptor 4 (TLR4) initiates a
sequential activation of IL-1 receptor-associated kinases
(IRAKs), tumor necrosis factor (TNF)-receptor-associated
factor 6 (TRAF6), nuclear factor κB inducing kinase (NIK),
and the IκB kinase complex (IKKs). IKK activation induces
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phosphorylation and degradation of IκB followed by acti-
vation of nuclear factor κB (NFκB) [1]. NFκB induces the
activation of proinflammatory cytokines, especially TNF
and IL-1β, which are well-known for their cardiodepres-
sive effects [2].
Innate immunity is involved in myocardial ischemia/
reperfusion (MI/R) injury, specifically through activation
of TLR4, which was originally proposed to solely recog-
nize lipopolysaccharide (LPS) [3]. Other cell products
than LPS, may be released from injured tissue and are
potential ligands of TLR4. Among these ligands are heat
shock proteins (HSP) 60 and 70, and matrix proteins,
such as fibrinogen, fibronectin and hyaluronic acid [4-7].
Thus, these ligands, which can be released by necrosis,
may compound reperfusion injury by activation of the
TLR4 signaling pathway. Consistent with this hypothesis,
Oyama et al. demonstrated that in TLR4-deficient mice
infarct size and signs of inflammatory response were sig-
nificantly decreased after MI/R [8]. Moreover, Chong et al.
showed in the same strain that myocardial mRNA expres-
sion of the cytokines IL-1β and IL-6 was significantly
lower after MI/R, when compared to their wild type litter-
mates. Surprisingly, MI/R did not induce significant TNF
expression in either WT or TLR-4 deficient mice [9]. In
contrast, other studies have shown that MI/R increases
myocardial TNF [2]. However, it remains unclear whether
subsequent effects of TLR4-activation during MI/R injury
are beneficial or deleterious for cardiac function. Recent
studies have demonstrated that TLR4 mediates survival in
cardiac myocytes and that LPS treatment could be cardio-
protective in certain settings. [10-13].
It has not been shown that a reduction in infarct size in
the TLR4-deficient mice results in improved hemodynam-
ics and cardiac function. The expression of cytokines after
MI/R is unclear with conflicting reports [2,9]. Therefore,
we investigated the importance of TLR4 for cardiac func-
tion in TLR4-deficient (C3H/HeJ) and wild type mice
(WT, C3H/HeN) in a murine model of chronic, closed-
chest MI/R. Furthermore, we measured myocardial and
serum cytokine levels to determine if locally and systemi-
cally expressed TNF, IL-1β and IL-6 are regulated via TLR4
following MI/R.
Results
Infarct Size
Infarct size in C3H/HeJ mice was significantly reduced at
30.1 ± 4.8% of the area at risk (AAR; figure 1) compared
to WT (49.1 ± 6.6%). AAR as a percentage of the left ven-
tricle was 46.8 ± 1.9% and 42.5 ± 1.7% in WT (n = 10) and
in C3H/HeJ mice (n = 15), respectively (p = ns, figure 1).
Cardiac Function
In WT, the heart rate increased from 372 ± 22 min-1 before
ischemia to 459 ± 26 min-1 (p < 0.05) after 60 min of
ischemia (figure 2). Unexpectedly, heart rate in C3H/HeJ
was higher at baseline, 459 ± 18 min-1, and did not change
throughout the protocol (465 ± 22 min-1 after 60 min of
ischemia). Echocardiography detected no difference in
ejection fraction (EF) between sham-operated WT (n =
14) and C3H/HeJ (n = 7) mice (62.6 ± 2.2% and 56.2 ±
3.4%, respectively, p = ns). 24 h following MI/R (figure
3A), EF was similarly reduced in WT (42.3 ± 2.1%, n = 6)
and C3H/HeJ mice (37.0 ± 3.7%, n = 6, p = ns), reflecting
moderate infarction.
Heart rate before and during MI/R measured with ECG (WT:  n = 12, C3H/HeJ: n = 12, *p < 0.05 vs C3H/HeJ, §p < 0.05 vs  baseline) Figure 2
Heart rate before and during MI/R measured with ECG (WT: 
n = 12, C3H/HeJ: n = 12, *p < 0.05 vs C3H/HeJ, §p < 0.05 vs 
baseline).
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Area at risk as a percentage of left ventricle (AAR/LV) and  myocardial infarct size as a percentage of area at risk (IS/ AAR) in both experimental groups assessed by TTC staining Figure 1
Area at risk as a percentage of left ventricle (AAR/LV) and 
myocardial infarct size as a percentage of area at risk (IS/
AAR) in both experimental groups assessed by TTC staining. 
There was no significant difference in area at risk of left ven-
tricle indicating equal position of LAD occlusion. Infarct size 
is significantly smaller in C3H/HeJ mice (WT: n = 10, C3H/
HeJ: n = 15; *p < 0.05).BMC Physiology 2007, 7:5 http://www.biomedcentral.com/1472-6793/7/5
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Immediately after echocardiography, hemodynamic
parameters were assessed (figure 3B). In three C3H/HeJ
MI/R mice, catheterization was technically not feasible.
There was no significant difference between groups with
respect to heart rate 24 h after MI/R. Contractility (+dp/
dtmax) and relaxation (- dp/dtmin) showed a tendency
towards impaired LV function in C3H/HeJ mice (table 1).
Although both groups of mice had similar EF by echocar-
diography, a marked difference was seen in LV developed
pressure (63.0 ± 4.2 mmHg in C3H/HeJ, n = 3 vs 77.9 ±
1.7 mmHg in WT, n = 6, p < 0.05, table 1).
Heart weight: Post-Ischemia Myocardial Edema
Differences in cytokine expression in response to ischemia
could contribute to differences in myocardial wall edema
post-ischemia, and effect function. Post-ischemic myocar-
dial wall edema can contribute to stiffness of the heart and
potentially protect ejection fraction [14]. Therefore, we
measured heart dry and wet weight for post MI/R myocar-
dial edema, as well as heart to body weight ratio. No sig-
nificant differences were found between C3H/HeJ (n = 6)
and WT MI/R (n = 5) and corresponding sham groups
(table 2).
Myocardial TNF, IL-1β and IL-6
Activation of TLR4 induces production of the pro-inflam-
matory cytokines TNF, IL-1β and IL-6. We measured myo-
cardial cytokine expression after two hours of reperfusion
(figure 4). As might be expected, WT myocardial IL-6 lev-
els were higher compared to both WT sham and to C3H/
HeJ after MI/R. However, there was no difference in IL-1β
levels in WT vs. C3H/HeJ mice after MI/R. Likewise, TNF
did not differ between the two groups after MI/R. Interest-
ingly, C3H/HeJ with MI/R had higher myocardial IL-1β
and IL-6, but not TNF levels, than their respective sham
group (p < 0.05), (table 3A). This suggests TLR4-inde-
pendent induction of IL-1β and IL-6 after MI/R. For WT,
all three cytokine levels were higher after MI/R vs. sham (p
< 0.05)
Serum Levels of TNF, IL-1β and IL-6
We determined TNF, IL-1β and IL-6 levels in serum (table
3B). For all cytokines, significantly higher serum levels
were seen in WT (n = 5) following MI/R compared to
C3H/HeJ mice (n = 5, figure 5). TNF was 491.1 ± 138.6pg/
mL in WT MI/R, whereas in C3H/HeJ serum level was
8.4% of WT (41.2 ± 9.6 pg/mL, p < 0.05). Similarly, IL-1β
was 3.7 times higher in WT than in C3H/HeJ (314.9 ±
76.3 pg/mL vs. 85.9 ± 32.2 pg/mL, p < 0.05). Serum IL-6
was 1.6 times higher in WT MI/R (1890.6 ± 78.6 pg/mL, n
= 5) compared to C3H/HeJ MI/R (1178.1 ± 314.2 pg/mL,
n = 5, p < 0.05). As would be expected, for WT, all
cytokines were higher with MI/R vs. sham treatment. In
contrast, only IL-6 was significantly elevated in the C3H/
HeJ MI/R vs. sham treatment (table 3B). Thus, in the
C3H/HeJ mice, only IL-6 increased after MI/R, while TNF
and IL-1β were unaffected.
Discussion
MI/R and Innate Immunity
Innate immunity is a rapid-response defense system,
employing receptors that can recognize a broad spectrum
of pathogens without prior sensitization, as is needed for
acquired immunity. The innate immune system contrib-
utes to cardioprotective effects following preconditioning
as well as to possible deleterious effects following MI/R.
Several studies have shown that sublethal doses of LPS
mediate cardioprotective effects, by attenuating activation
Table 1: Hemodynamic and echocardiographic parameters
Strain Heart rate 
(bpm)
LVDevP 
(mmHg)
+dp/dtmax 
(mmHg·s-1)
- dp/dtmin 
(mmHg·s-1)
ESV (μL) EDV (μL)
WT 588.4 ± 33.6 77.9 ± 1.7* 7887.5 ± 317.3 -5554.9 ± 402.6 32.4± 3.4 55.6± 4.5
C3H/HeJ 587.7 ± 11.4 63.0 ± 4.2 6651.0 ± 1383.0 -6117.2 ± 1129.4 33.8 ± 5.8 52.2 ± 6.1
Hemodynamic measurements (WT n = 6, C3H/HeJ: n = 3) and echocardiography (WT n = 6, C3H/HeJ: n = 6) were performed 24h after MI/R. 
Hemodynamic parameters showed no significant difference for contractility (+ dp/dtmax) and relaxation (- dp/dtmin). However, left-ventricular 
developed pressure (LVDevP) was significantly higher in WT. End-systolic left-ventricular volume (ESV) and end-diastolic left-ventricular volume 
(EDV) showed no difference. *p < 0.05.
Cardiac function determined by ejection fraction (EF%) and  LV developed pressure (LVDevP), measured with echocardi- ography (WT: n = 6, C3H/HeJ: n = 6) and LV-catheter (WT:  n = 6, C3H/HeJ: n = 3, *p < 0.05) Figure 3
Cardiac function determined by ejection fraction (EF%) and 
LV developed pressure (LVDevP), measured with echocardi-
ography (WT: n = 6, C3H/HeJ: n = 6) and LV-catheter (WT: 
n = 6, C3H/HeJ: n = 3, *p < 0.05).
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of NFκB and reduced expression of proinflammatory
cytokines [15-17]. In contrast, previous studies from our
laboratory have identified TLR4 as mediating LPS-induced
impairment of LV function, cardiac myocyte contractility,
intramyocardial cytokine expression and NO production,
as well as significant activation of myocardial NFκB, in a
model of LPS induced myocardial dysfunction [18-21].
Thus, the role of TLR4 in cardiac injury is complex and not
well understood.
Findings of the present study
The most important and novel finding of the present
study is that despite smaller infarcts, cardiac function was
not preserved in TLR4-deficient mice. We investigated car-
diac function with echocardiography and hemodynamic
measurements. Both methods confirmed that cardiac
function was not preserved in TLR4-deficient mice despite
a smaller infarct size. We found that expression of the car-
diodepressive cytokines TNF and IL-1β did not differ
between TLR4-deficient and WT mice hearts. On the other
hand, WT mice showed a robust expression of systemic
cytokines compared to TLR4 deficient mice. Thus, the
TLR4 pathway could play a more prominent role in the
systemic inflammatory reaction than locally in the heart
after MI/R.
In contrast to other recent MI/R studies with TLR4-defi-
cient mice, we employed a closed-chest model, which
allows cytokine levels to return to baseline levels after sur-
gery and before initiation of ischemia [22]. Importantly,
MI/R in the present study was conducted under condi-
tions of spontaneous breathing. Mechanical ventilation in
Myocardial protein expression of TNF, IL-1β and IL-6 in WT and C3H/HeJ mice following MI/R and 2 hours of reperfusion or  sham operation determined with ELISA Figure 4
Myocardial protein expression of TNF, IL-1β and IL-6 in WT and C3H/HeJ mice following MI/R and 2 hours of reperfusion or 
sham operation determined with ELISA. TNF and IL-1β levels were increased, but not signficantly in WT mice compared with 
C3H/HeJ. IL-6 was significantly higher in WT mice (16.0 ± 3.2 pg/mg protein vs. 8.0 ± 1.1 pg/mg protein). *p < 0.05 vs C3H/HeJ 
MI/R, § p < 0.05 vs WT MI/R, # p < 0.05 vs C3H/HeJ MI/R.
Table 2: Heart wet/dry weights, heart/body weight ratio
Treatment strain Heart wet/dry Heart wet/body weight (%)
MI/R WT (n = 5) 3.5 ± 0.5 0.34 ± 0.01
C3H/HeJ (n = 6) 3.7 ± 0.4 0.32 ± 0.01
Sham WT (n = 5) 4.0 ± 0.4 0.33 ± 0.01
C3H/HeJ (n = 6) 3.5 ± 0.5 0.30 ± 0.02
Heart wet to dry weight ratio and heart wet to body weights. p = nsBMC Physiology 2007, 7:5 http://www.biomedcentral.com/1472-6793/7/5
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an open-chest model induces an arterial hypotension due
to loss of negative intrathoracic pressure and positive end-
expiratory pressure as Guo et al. have described [23].
Recently, Oyama et al. reported a reduced infarct size in
TLR4-deficient mice strains compared to WT in an open-
chest model, with less inflammation in the myocardium,
manifested by less neutrophils, myeloperoxidase, lipid
peroxides and complement deposition [8]. Our data are
in good agreement with Oyama's results with respect to
infarct size.
Although several studies have shown that MI/R increases
myocardial TNF concentrations, which contributes to irre-
versible tissue injury and myocardial dysfunction [2],
Chong et al. reported that TNF mRNA expression was not
increased after MI/R in wild type and C3H/HeJ mice com-
pared to sham-operated mice, whereas myocardial mRNA
expression of IL-1β, monocyte chemotactic factor-1 and
IL-6 was significantly increased in wild type mice [9].
Although cytokine expression is thought to be primarily
regulated at the transcriptional level, post-transcriptional
events can alter gene expression. Therefore, we measured
the actual level of the three cytokines and found signifi-
cantly higher myocardial TNF, IL-1β and IL-6 expression
in WT MI/R compared to shams, which confirms other
studies showing that myocardial TNF is increased during
MI/R [2]. Most striking, there was no significant difference
for myocardial TNF between wild type and C3H/HeJ mice
after MI/R, and similar levels of protein expression were
also found for IL-1β. Only myocardial IL-6 protein
expression was significantly decreased in TLR4-deficient
mice compared to WT after MI/R. This led us to the con-
clusion that the regulation of myocardial cytokines differs
from the regulation of serum cytokines, and that at least
TNF and IL-1β are not primarily regulated through TLR4
in myocardial ischemia/reperfusion.
Mechanical stress is associated with myocardial infarction
triggering myocardial production of TNF and IL-6, not
only in the infracted, but also in the non-infarcted region
of the heart [24,25]. TNF, IL-1β and IL-6 contribute to car-
diac dysfunction through activation of neutral sphingo-
myelinase and NO production [26,27]. However, we did
not observe differences in myocardial cytokines between
WT and C3H/HeJ MI/R, except for IL-6, which was signif-
icantly decreased in TLR4-deficient MI/R mice. The role of
myocardial cytokines on cardiac function in the present
study remains unclear. Deten et al. have suggested that IL-
6 and IL-1β synergistically promote compensatory cardiac
hypertrophy in the non-infarcted myocardium, [28] and
other studies provide evidence that IL-6 also protects car-
diac myocytes from apoptosis [29]. Numerous myocar-
dial infarction studies have shown pleiotropic effects of
these cytokines and their specific effects on cardiac func-
tion remain to be fully elucidated. It has to be considered
that the absence of TLR4, not only reduces infarct size, but
also other regulatory proteins, such as the chemokine
monocyte chemoattractant protein (MCP)-1, which may
prolong inflammation and delay replacement of injured
cardiac myocytes [30].
Serum cytokines did not reflect myocardial cytokine
expression, and were significantly less in TLR4-deficient
Table 3: Myocardial and serum TNF, IL-1β and IL-6 expression
A
Treatment strain TNF heart IL-1β Heart IL-6 heart
MI/R WT 3.9 ± 0.7*# 6.9 ± 0.7*# 16.0 ± 3.2*#‡
C3H/HeJ 1.8 ± 0.7 5.7 ± 0.8* 8.0 ± 1.1*
Sham WT 1.2 ± 0.6 2.4 ± 0.6 0.9 ± 0.2
C3H/HeJ 0.9 ± 0.4 3.1 ± 0.4 1.9 ± 0.2
B
Treatment strain TNF serum IL-1β Serum IL-6 serum
MI/R WT 491.1 ± 138.6† 314.9 ± 76.3† 1890.6 ± 78.6†
C3H/HeJ 41.2 ± 9.6 85.29 ± 32.2 1178.1 ± 314.2¥
Sham WT 17.3 ± 7.2 17.3 ± 7.2 17.3 ± 7.2
C3H/HeJ 10.6 ± 3.2 26.0 ± 5.6 74.5 ± 23.1
A Myocardial and B serum protein levels of TNF, IL-1β and IL-6 in WT and C3H/HeJ mice following MI/R and 2 hours of reperfusion or sham 
operation determined with ELISA. All serum cytokines were significantly higher in WT mice which underwent MI/R compared to C3H/HeJ. n = 5 
for each group, *p < 0.05 vs C3H/HeJ sham, #p < 0.05 vs. WT sham, ‡ p < 0.05 vs C3H/HeJ MI/R, † p < 0.05 vs all groups, ¥ p < 0.05 vs. WT sham 
and C3H/HeJ shamBMC Physiology 2007, 7:5 http://www.biomedcentral.com/1472-6793/7/5
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mice compared to their WT littermates. Our data supports
that ischemia stimulates cytokine expression via TLR4-
independent mechanisms (such as mechanical stretch),
resulting in similar myocardial levels of TNF and IL-1β in
both strains. With the onset of reperfusion in TLR4-defi-
cient mice, cytokine and chemokine signaling is disturbed
because of the non-functional TLR4-receptor. This can
result in decreased chemotaxis of leukocytes. Alteration in
the inflammatory response to myocardial infarction may
account for the observed discrepancy between infarct size
and cardiac function for the TLR4 deficient mice.
A recent study has shown that TLR4 in cardiac myocytes
mediates survival through MyD88 and NOS2 using TLR4
-/- cardiac myocytes in comparison to wild type in a
model of serum deprivation induced apoptosis [10].
Other studies confirm that LPS, as a ligand of TLR4, can be
cardioprotective [11-13]. It remains to be elucidated if
TLR4 is essential for in vivo myocardial function and pro-
tection from cardiac myocyte apoptosis after MI/R. It is
unclear, if TLR4 deficiency ameliorates reperfusion injury
due to blunted systemic inflammatory response as shown
by our present study but leads to myocardial dysfunction
due to apoptosis in addition to TLR4 independent
cytokine expression.
Differences in heart rate
In this study, mice were sedated with propofol i.p. for
induction of MI/R. Propofol was chosen because of its
lack of preconditioning effects. However, we found a sig-
nificant decrease in heart rate only in WT, probably an
effect of propofol which has been also reported in C57Bl/
6 mice [31]. With the onset of ischemia, heart rate
increased which was attributed to stress. Interestingly, in
C3H/HeJ mice propofol did not decrease heart rate. We
also observed an invariable heart rate with onset of MI/R
compared to WT. The mechanism underlying absence of
heart rate increase despite stress of MI/R in these mice is
unknown.
Conclusion
TLR4 contributes to myocardial infarction by inducing a
systemic and a myocardial cytokine response after MI/R. It
has to be considered that TLR4-independent pathways are
also activated due to MI/R and contribute to myocardial
dysfunction. The targeted pharmacologic inhibition of
TLR4 in the clinical setting of myocardial ischemia and
reperfusion could initially lead to a smaller infarct, but an
altered inflammatory response could have unexpected
effects on cardiac function and long term infarct healing.
Thus, further investigations are needed to elucidate the
Serum protein levels of TNF, IL-1β and IL-6 in WT and C3H/HeJ mice following MI/R and 2 hours of reperfusion or sham  operation determined with ELISA Figure 5
Serum protein levels of TNF, IL-1β and IL-6 in WT and C3H/HeJ mice following MI/R and 2 hours of reperfusion or sham 
operation determined with ELISA. All cytokines were significantly higher in WT mice which underwent MI/R compared to 
C3H/HeJ. TNF serum levels were 491.1 ± 138.6 pg/mL and 41.2 ± 9.6 pg/mL in WT MI/R and C3H/HeJ MI/R, respectively. IL-
1β serum levels were 314.9 ± 76.3 pg/mL and 85.9 ± 32.2 pg/mL in WT MI/R and C3H/HeJ MI/R, respectively. Serum IL-6 was 
1.6 times higher in WT (1890.6 ± 78.6 pg/mL) compared to C3H/HeJ (1178.1 ± 314.2 pg/mL). *p < 0.05 vs all groups, #p < 0.05 
vs. WT sham.BMC Physiology 2007, 7:5 http://www.biomedcentral.com/1472-6793/7/5
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role of TLR4 in infarct size, modulating inflammatory
responses and its impact on cardiac function.
Methods
Ischemia/Reperfusion experiments
A chronic, closed-chest model of MI/R was utilized in
order to exclude that any inflammatory reaction following
MI/R is due to the surgical trauma itself. Male, 8–12 weeks
old C3H/HeJ (n = 15) and WT (C3H/HeN, n = 10; Charles
River, Sulzfeld, Germany) were anesthetized with isoflu-
rane 2.5 Vol.% (Forene®, Abbott GmbH, Wiesbaden, Ger-
many) with 1 L*min-1 O2 flow. After sufficient anesthesia
depth was confirmed by squeezing the paws, animals
were placed in a supine position for intubation on a water
warmed plate. Body temperature and electrocardiography
(ECG) were monitored and surgery was performed, as
described previously [22]. The nose was placed in a nasal
cone which was connected to an isoflurane vapor to main-
tain anesthesia during the intubation procedure. The head
was slightly reclined by fixing the upper incisors with a 6-
0 suture to facilitate intubation. Ventilation was con-
firmed by observing thorax excursions and adopted to
physiological parameters (Minivent, HUGO SACHS ELE-
KTRONIK-HARVARD APPARATUS GmbH, March-Hug-
stetten, Germany, respiratory rate 105*min-1, 200 μl tidal
volume). A left parasternal incision through the third and
fourth rib was made. The chest walls were separated with
retractors to achieve a good visualization of the heart. The
pericardium was then gently opened and the heart was
rotated on its longitudinal axis to identify the LAD with a
mini tip cotton applicator (Hardwood Products Com-
pany, Guilford, Maine, USA). A U-shaped 8-0 tapered nee-
dle was cautiously passed underneath the LAD 1 mm
distal from the tip of the left auricle. The 8-0 prolene
suture was cut at the needle side and both ends were
threaded through a 1 mm section of a PE 10 tube. Both
ends of the suture were tightened to confirm the correct
position of the suture by observing paleness of the distal
myocardium. The following procedure was modified
according to Nossuli et al. [22] who exteriorized each end
of the suture with a size 3 Kalt suture needle (FST, Fine Sci-
ence Tools GmbH, Heidelberg, Germany) to both sides of
the thorax. Instead, we passed both ends of the suture out
to the left side of the thorax, one through the second inter-
costal space and one through the fourth intercostal space
and formed a loop by knotting each end to the other. With
this modified technique we prevented a longitudinal rota-
tion of the heart when the suture ends were pulled apart
as observed with echocardiography. This rotation could
potentially lead to hemodynamic changes (data not
shown). The loop was then left in the subcutaneous tis-
sue. The chest was closed with three 6-0 prolene sutures.
Anesthesia was turned off while closing the skin. After
mice regained spontaneous breathing they were extubated
and allowed to breathe 100% O2.
For MI/R experiments, mice were sedated with propofol
i.p. (150 mg*kg-1 BW), allowing spontaneous breathing,
and were placed in a supine position on a warming plate
beneath a heating lamp to maintain body temperature,
which was monitored with a rectal probe. The ECG was
monitored to document ST-segment elevation (PowerLab,
ADInstruments GmbH, Spechbach, Germany). The
former skin incision was reopened and after dissecting the
loop, tension was carefully applied to the loop to achieve
and maintain a significant ST-elevation. After 60 minutes,
the loop was relaxed and it was taken care of monitoring
a resolution of the ST-segment elevation as a sign of reper-
fusion. The loop was placed back into the subcutaneous
tissue and the skin was closed. Sham-operated mice
underwent the same procedure except for pulling the loop
to induce myocardial ischemia/reperfusion. The time
course of the MI/R protocol is summarized in figure 6. For
myocardial and serum cytokine levels, animals were anes-
thetized following 2 hours of reperfusion, blood was col-
lected and hearts were snap-frozen with liquid nitrogen.
The specimens were stored at -80°C for further analyses.
The animals were handled according to the principles of
laboratory animal care (NIH publication No. 85–23,
revised 1996), and animal procedures were approved by
the local committee for animal care.
Assessment of infarct size
In vivo, 10% phthalo blue (Heucotech LTD, Fairless Hills,
PA, USA) was injected into the left atrium 24 h following
MI/R to determine the area at risk (AAR) [32]. Hearts were
excised, rinsed with phosphate buffer solution (PBS) and
frozen in isopentane at -160°C. Thereafter, they were cut
into 7 transverse slices and incubated with 1.5% triphe-
nyltetrazolium chloride (TTC, Sigma-Aldrich Chemie
GmbH, Munich, Germany) at 37°C for 20 min in order to
visualize the infarct area (figure 7). Infarct Size (IS), AAR
and the phthalo blue stained areas were measured with a
Mice were allowed to recover from instrumentation for 4  days Figure 6
Mice were allowed to recover from instrumentation for 4 
days. LAD was occluded for 60 minutes to induce myocardial 
infarction. Echocardiography and hemodynamic measure-
ments were performed before hearts were excised 24 hours 
following ischemia for TTC staining and post-mortem analy-
ses.
Instrumentation
LAD
Occlusion
Echocardiography
Hemodynamics
TTC
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planimetry software by investigators unaware of sample
identity (ImageJ, Version 1.29, NIH, USA). IS was calcu-
lated in percentage of the AAR.
Echocardiographic Image Acquisition
C3H/HeJ (n = 6) and WT (n = 6) were anesthetized and
heart function was assessed 24h following MI/R, as
described before [33]. In brief, mice were anesthetized
with sevoflurane (4% for induction, 1.5–1.8% for mainte-
nance) in 50% nitrous oxide and 50% oxygen by face-
mask. Echocardiography was performed with a Philips-
Ultrasound (HDI-5000) equipped with a linear-array
transducer (CL15-7) operating at 15 MHz and providing
frame rates up to 284 Hz. A parasternal long-axis image
was used to guide perpendicular angulation of the trans-
ducer in acquisition of the short-axis slices. The most
basal image was obtained by visualizing the base of the
aortic root, as published recently [34]. In brief, sequenced
2D parallel short-axis images of the left ventricle were
obtained in 500μm steps towards the apex by means of a
micrometer-screw driven tripod. Ten to fourteen short-
axis segments were recorded depending on the overall size
of the left ventricle. Parasternal short-axis views were vis-
ually divided into six segments. Imaging was considered
adequate when the endocardial and epicardial borders
could be properly visualized in at least five segments.
Cineloops of 50 frames covering minimum two heart
cycles were stored digitally and analysed off-line.
Echocardiographic Image Analysis
A practiced, single, blinded observer performed echocar-
diographic analyses. End-diastolic measurements were
obtained at the peak of the R-wave, whereas end-systolic
measurements were obtained at the time of minimum
internal chamber dimensions. The acquired sequential
2D short-axis cineloops of the left ventricle were used to
measure left-ventricular volumes at end-diastole and end-
systole and ejection fraction (EF).
Hemodynamic measurement of LV function
Hemodynamic measurements of LV function were
obtained immediately following echocardiography after
24 h of MI/R. LV function was assessed using a 1.4-Fr
Mikro-tipped Millar catheter as described previously [21].
Briefly, the right carotid artery was dissected under a
microscope and a 1.4-Fr Mikro-tipped Millar catheter
(Millar Instruments; Houston, Texas) was advanced into
the left ventricle. The transducer was connected to a com-
puterized data acquisition system (PowerLab, ADInstru-
ments, Grand Junction, Colorado). The Chart 4 data
A Representative example of a heart slice from a WT mouse (C3H/HeN) stained with TTC Figure 7
A Representative example of a heart slice from a WT mouse (C3H/HeN) stained with TTC. Infarct areas are not stained by 
TTC (white), AAR is stained red (TTC positive). Myocardium which is not perfused by LAD is stained blue by phthalo blue 10 
% (pblue). Infarct involves almost all the AAR. B Representative example of a TTC stained myocardial slice of a TLR4-deficient 
mice (C3H/HeJ). IS is clearly smaller in comparison to a matchable slice of a wild type mice, pblue = phthaloblue, AAR = area 
at risk, PM = papillary muscle.
infarct
AAR
pblue
PM
pblue
AAR
infarct
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analysis software (ADInstruments) was used to calculate
heart rate (HR), left-ventricular developed pressure
(LVDevP) and its maximal positive and negative first
derivative with respect to time (+dP/dtmax, -dP/dtmin).
Heart Weight
C3H/HeJ and wild type mice underwent either MI/R (n =
5) or sham (n = 6) procedure to evaluate if differences in
post-MI/R myocardial edema could contribute to myocar-
dial dysfunction. Body weights were assessed and hearts
excised after 24 h of MI/R or corresponding time in sham
and rinsed shortly with PBS. Left ventricular and total
heart weights were determined. Afterwards, hearts were
dried at 80°C for 40 min. to determine dry weights. Ratio
of left-ventricular wet to dry weights as well as ratios of
wet to body weight were calculated.
Myocardial TNF, IL-1β and IL-6 protein expression
To determine TNF, IL-1β and IL-6 protein expression after
2 hours of reperfusion, snap-frozen myocardial tissue was
homogenized and incubated on ice for 5 min in 1 mL of
ELISA buffer containing PBS, Triton X-100 (1 μL/mL,
Sigma), PMSF (250 mM in isopropanol, 1 μL/mL, Sigma,
Taufkirchen, Germany) and protease inhibitors (Cat.
1836153, Roche, Mannheim, Germany). Samples were
incubated on ice for 20 min, homogenized and centri-
fuged for 15 min at 4°C at 16,100 g. The supernatant was
used for measuring myocardial TNF, IL-1β and IL-6 pro-
tein levels with ELISA (R&D Systems, Minneapolis, USA).
Protein expression of TNF, IL-1β and IL-6 in serum
Blood was taken after 2 hours of reperfusion. Serum was
assayed for levels of TNF, IL-1β and IL-6. A standard com-
mercially available sandwich ELISA (R&D Systems, Min-
neapolis, USA) with a polyclonal antibody, specific for the
murine recombinant cytokine, was used.
Statistics
All values are expressed as mean ± SEM. Student's t-test
was used for comparison of myocardial infarction size
and cardiac function between groups. A one-way ANOVA
for repeated measurements was used for heart rate. A
Mann-Whitney rank sum test was used for comparison of
hemodynamic values. One-way ANOVA on Ranks was
used for comparison of heart weights. One-way ANOVA
was used for comparison of cytokine levels followed by a
Holm-Sidak pairwise multiple comparison. Differences
among experimental groups were considered significant
with p < 0.05.
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